Skip to content

Quality of Recovery Scores in Parturients With Obesity

Quality of Recovery Scores in Parturients With Obesity: A Prospective Observational Cohort Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04988893
Enrollment
140
Registered
2021-08-04
Start date
2021-08-09
Completion date
2023-03-18
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Operative Pain, Quality of Recovery

Keywords

Cesarean Section, Parturients, Morbid Obesity

Brief summary

The prevalence of obesity has increased dramatically recently. Obesity is a pro-inflammatory state which leads to chronic low grade inflammation having different systemic effects. This may make obesity an independent risk factor for severe acute postoperative pain. No prospective studies have been conducted to specifically evaluate the quality of recovery after caesarean delivery for women with morbid obesity when compared to non-obese parturients. In addition, while there is biological plausibility to infer worse pain scores in parturients with obesity, the magnitude of this difference is unknown and information guiding adjustments in pain management are lacking.

Detailed description

The prevalence of obesity has increased dramatically over the recent past in both developed and developing countries. Obesity is a pro-inflammatory state which leads to chronic low grade inflammation. It has been well studied that this very inflammation and oxidative stress is responsible for cardiovascular pathologies seen in these patients. As a result, the post-operative period is characterized by a phase of prolonged systemic inflammatory response, which makes obesity an independent risk factor for severe acute pain. As a matter of fact, an extreme rise in IL-6 in patients with obesity has been demonstrated post-operatively. In addition, adipose tissue acts as an endocrine organ by releasing a number of other pro-inflammatory proteins. Cytokines are known to promote various metabolic, hemodynamic and immunologic changes post-surgery, and in the setting of exaggerated inflammatory response can lead to increased pain and hemodynamic instability. Very few studies have evaluated the recovery experience of patients with obesity in the acute postoperative period. Patients with obesity undergoing general abdominal surgery have been shown to have worse surgical outcomes, increased complication rates, and increased analgesic requirements.7 However, in spine surgery, there have been conflicting evidence supporting a difference in pain scores in patients with obesity. Despite there being no clear guidelines on post-operative pain control between these two groups, providers reported prescribing less opioid analgesics post-operatively to patients with obesity when compared to patients not suffering from this condition. The Obstetric Quality of Recovery Score (ObsQoR) was initially developed and validated as a measure of patient reported outcome after caesarean delivery. It started as an 11-item questionnaire (ObsQoR-11), which was further simplified to 10-items (ObsQoR-10) following patient feedback where moderate and severe pain questions were combined into a single item. This tool measures pain, nausea or vomiting, dizziness, shivering, comfort, mobility, ability to hold and feed the baby, personal hygiene maintenance, and feeling in control, to provide a global inpatient postpartum quality of recovery score out of 100. A systematic review assessing measurement properties of available patient-reported outcome measures using COSMIN (COnsensus-based Standards for the selection of health Measurement INstruments) methodology, recommended ObsQoR as the best available instrument to measure functional recovery following caesarean delivery. No prospective studies have been conducted to specifically evaluate the quality of recovery after caesarean delivery for women with morbid obesity when compared to non-obese parturients. In addition, while there is biological plausibility to infer worse pain scores in parturients with obesity, the magnitude of this difference is unknown and information guiding adjustments in pain management are lacking. The investigators hypothesize that parturients with Class 3 obesity experience impaired quality of recovery scores after elective cesarean delivery as measured by the ObsQoR-10 when compared to non-obese parturients.

Interventions

None listed

Sponsors

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> 18 years * Term pregnancy (\> 37 weeks gestational age) * Elective caesarean delivery * BMI \>40 (Study Group) or BMI \<30 (Control Group) * ASA\<=3

Exclusion criteria

* Chronic pain * History of opioid use during pregnancy. * History of substance abuse disorder during pregnancy. * Contraindication to neuraxial opioids, acetaminophen and/or NSAIDs * Language barrier * Allergy to Opioids or NSAIDS * Intra-operative conversion to general anesthesia * Maternal Admission to ICU. * Neonatal admission to NICU.

Design outcomes

Primary

MeasureTime frameDescription
Difference in Obstetric Quality of Recovery Score (ObsQoR-10)24 hours post cesarean delivery10-item questionnaire applied to subjects 24 hours after spinal anesthesia. Measured in a 0-100 scale where 0=poor recovery and 100=perfect recovery

Secondary

MeasureTime frameDescription
Opioid Consumption in the first 24 hours24 hours post cesarean deliveryBetween-group difference in the total amount of Oral Morphine Equivalents consumed in the first 24 hours after surgery.
Total Inpatient Opioid Consumptionup to 1 week post operativelyBetween-group difference in the total amount of Oral Morphine Equivalents consumed during hospital stay.
Time-to-first oral opioid analgesic requestMeasured in hours from the time of cesarean delivery until patient request for prescribed oral opioid analgesia, up to 24 hours from the spinal anestheticThis is defined as the length of time between cesarean delivery and the first time the subject requested additional opioid analgesia
Respiratory DepressionIn post-anesthesia care unit (PACU), and every 4 hours up to 24 hours after surgeryThis is defined as respiratory rate\<8 breaths/minute, need for naloxone or need for clinical intervention.
Nausea and/or Vomiting that required treatmentAbsolute number of treatments required in the 24-hour time frameNausea/Vomiting episodes that required pharmacological treatment in the first 24 hours post operatively
Difference in Average Numeric Rating Score (0-10 , where 0=no pain and 10= maximum pain) at specific time points in the first 24 hoursImmediately after surgery (in PACU) and every 4 hours up to 24 hours after surgeryThis is defined as the between- group difference in the mean pain scores on a 0-10 Numeric Rating Scale, as assessed by one of the investigators immediately after surgery (in the Post-Anaesthesia Care Unit) and every 4 hours up to 24 hours after surgery
Breastfeeding24 hours post cesarean deliveryMother breastfeeding at 24 hours: Yes or No
Time to fist mobilizationMeasured in hours from the time of cesarean delivery until patient first mobilizes post operatively, up to 48 hours post operatively.Time to fist mobilization (standing and walking independently): measured in hours
Time to first oral intakeMeasured in hours from the time of cesarean delivery, up to 48 hours post operativelyTime to first oral intake (non-clear fluids): measured in hours
Length of hospital stayMeasured in hours from the time of cesarean, up to to 1 month post operatively (average 48-72 hours)Length of hospital stay: measured in hours.
Unplanned Readmission Rates6 weeks post opUnplanned Readmission Rates prior to 6-week follow up appointment: Yes or No and reason for readmission
Pruritus that required treatmentAbsolute number of treatments required in the 24-hour time frame.Pruritus episodes that required pharmacological treatment in the first 24 hours post operatively

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026